Weekly briefings on funding, launches, leadership moves and hiring signals across life sciences and industrial markets, from the QP Group specialists who work in them every day.
Funding, launches, leadership moves and hiring signals across the companies building the future of science and healthcare.
Infrastructure funding, contractor consolidation, project awards and leadership moves across US construction and manufacturing.
The stories that mattered last week, across every market we cover.
Orbia's HDPE conduit business grew Q3 revenue 47% to $373M, citing US data centre and telecom demand. EBITDA rose 68% and plants ran at high utilisation.
Read the full story →Juvia Group and Lightspeed co-led an oversubscribed round to take dibotatug, a CD94 antibody for two rare blood cancers, through a filing and towards launch.
Read the full story →Headline led the round for Electra, an AI agent that works inside health plans' prior auth queues. It can approve or escalate, but never denies.
Read the full story →Q3 revenue of $1,129M beat its own guidance on healthy clinical demand and NovaSeq X placements. Full-year revenue now seen at $4.64B to $4.66B.
Read the full story →Q3 EBITDA before special items rose 15% to €1.6bn. Kamieth called an Evonik deal logical, but said BASF won’t pay an excessive price.
Read the full story →91 grants in 37 states, led by $72M for a Kansas City grade separation. A day earlier, USDOT put $1.01B into 297 road safety projects.
Read the full story →Q3 revenue rose 28.8% to $5.54bn. Data centre RPOs of $8.74bn are now close to half the order book.
Read the full story →Immunology hit $9.17bn, up 16%, and neuroscience grew 19% to $3.39bn. The CEO wants bolt-on deals, not another Allergan.
Read the full story →Ten biopharmas have cut or plan to cut 4,062 plant roles, almost half of them at BioNTech. Teva added a Fairfield, NJ closure this week, even as Merck’s new Virginia plant could add 500+ jobs.
Read the full story →AI peak integration for Empower cut manual fixes from 90 to 4 in a pilot. It's subscription-only, with validated deployment expected mid-2027.
Read the full story →Q3 orders rose 10% organically but revenue was flat, so 2026 guidance came down. Xylem will divest two businesses and move to three segments from January.
Read the full story →September construction unemployment was 3.5% nationally, and all but three states were under 6%. Maryland hit a record-low 1.7%. ABC says data centres are absorbing a big share of skilled labour.
Read the full story →Read any newsletter in full.
3 Nov 2026 · HDPE Pipe
3 Nov 2026 · Biotech, R&D & Clinical
3 Nov 2026 · Digital Health & Healthcare AI
3 Nov 2026 · Genomics & Diagnostics
3 Nov 2026 · Materials Science & Cheminformatics
3 Nov 2026 · Heavy Civil & Infrastructure
Pick the markets you care about. Each is a three-minute weekly read, from the QP Group specialist for that market. No spam, one-click unsubscribe.
